New liquid form of seizure drug tested in kids as young as 1 month
NCT ID NCT06534502
Summary
This study aims to find the right dose and check the safety of a liquid form of the seizure medicine zonisamide for children and teens with partial-onset seizures. It will enroll 40 participants, from 1 month to 17 years old, who are already on a stable seizure medication plan. Researchers will measure the drug levels in the blood and monitor for side effects over several weeks to determine the best dosing schedule for this age group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Le Bonheur Children's Hospital
Memphis, Tennessee, 38103, United States
Contact
-
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27101, United States
Contact
Conditions
Explore the condition pages connected to this study.